NOT KNOWN DETAILS ABOUT SAFE PSYCHEDELICS

COMPASS Pathways, a mental health treatment corporation, acquired the designation for its psilocybin therapy for treatment-resistant depression in 2018. In 2019, Usona Institute, a nonprofit professional medical researcher, gained the designation to carry on its testing of psilocybin as a treatment for big depressive disorder.What actions could pol